Phytohealth Corp (4108) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Phytohealth Corp (4108) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$11.18 Million ≈ $352.14K USD) by net assets (NT$2.27 Billion ≈ $71.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Phytohealth Corp - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Phytohealth Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Phytohealth Corp carry for a breakdown of total debt and financial obligations.
Phytohealth Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Phytohealth Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Datagate Bilgisayar Malzemeleri Ticaret AS
IS:DGATE
|
1.726x |
|
RoyalTek Co Ltd
TWO:3306
|
-0.005x |
|
Maat Pharma SA
PA:MAAT
|
-1.853x |
|
Pelthos Therapeutics Inc.
NYSE MKT:PTHS
|
-0.161x |
|
TEKNA HOLDING ASA NK 2
F:8VB
|
N/A |
|
Gabriel Holding
CO:GABR
|
0.144x |
|
Gossamer Bio Inc
NASDAQ:GOSS
|
0.439x |
|
An Gia Real Estate Investment and Development Corp
VN:AGG
|
-0.167x |
Annual Cash Flow Conversion Efficiency for Phytohealth Corp (2005–2024)
The table below shows the annual cash flow conversion efficiency of Phytohealth Corp from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see Phytohealth Corp (4108) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$2.37 Billion ≈ $74.62 Million |
NT$-50.13 Million ≈ $-1.58 Million |
-0.021x | +12.24% |
| 2023-12-31 | NT$2.27 Billion ≈ $71.54 Million |
NT$-54.77 Million ≈ $-1.73 Million |
-0.024x | +8.36% |
| 2022-12-31 | NT$2.28 Billion ≈ $71.75 Million |
NT$-59.95 Million ≈ $-1.89 Million |
-0.026x | +7.86% |
| 2021-12-31 | NT$2.39 Billion ≈ $75.25 Million |
NT$-68.24 Million ≈ $-2.15 Million |
-0.029x | +67.11% |
| 2020-12-31 | NT$1.70 Billion ≈ $53.63 Million |
NT$-147.87 Million ≈ $-4.66 Million |
-0.087x | -25.30% |
| 2019-12-31 | NT$1.75 Billion ≈ $55.19 Million |
NT$-121.45 Million ≈ $-3.83 Million |
-0.069x | +4.67% |
| 2018-12-31 | NT$1.94 Billion ≈ $61.27 Million |
NT$-141.44 Million ≈ $-4.46 Million |
-0.073x | +0.29% |
| 2017-12-31 | NT$2.08 Billion ≈ $65.45 Million |
NT$-151.52 Million ≈ $-4.77 Million |
-0.073x | +77.69% |
| 2016-12-31 | NT$2.32 Billion ≈ $72.95 Million |
NT$-756.87 Million ≈ $-23.85 Million |
-0.327x | -472.14% |
| 2015-12-31 | NT$2.30 Billion ≈ $72.36 Million |
NT$-131.22 Million ≈ $-4.13 Million |
-0.057x | -304.42% |
| 2014-12-31 | NT$2.39 Billion ≈ $75.25 Million |
NT$-33.74 Million ≈ $-1.06 Million |
-0.014x | +68.58% |
| 2013-12-31 | NT$2.74 Billion ≈ $86.30 Million |
NT$-123.18 Million ≈ $-3.88 Million |
-0.045x | +23.87% |
| 2012-12-31 | NT$2.78 Billion ≈ $87.67 Million |
NT$-164.37 Million ≈ $-5.18 Million |
-0.059x | +46.05% |
| 2011-12-31 | NT$1.56 Billion ≈ $49.24 Million |
NT$-171.09 Million ≈ $-5.39 Million |
-0.109x | -3.32% |
| 2010-12-31 | NT$1.82 Billion ≈ $57.41 Million |
NT$-193.06 Million ≈ $-6.08 Million |
-0.106x | -98.88% |
| 2009-12-31 | NT$2.01 Billion ≈ $63.36 Million |
NT$-107.15 Million ≈ $-3.38 Million |
-0.053x | -181.31% |
| 2006-12-31 | NT$1.32 Billion ≈ $41.63 Million |
NT$86.57 Million ≈ $2.73 Million |
0.066x | +30.10% |
| 2005-12-31 | NT$1.19 Billion ≈ $37.44 Million |
NT$59.85 Million ≈ $1.89 Million |
0.050x | -- |
About Phytohealth Corp
PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. … Read more